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Table 2. Logistic regression analysis.
B S.E. Wald df Sig. Exp(B)
Diabetes Mellitus -,261 ,365 ,509 1 ,476 ,771
No-reﬂow 1,425 ,399 12,732 1 ,000 4,158
Arrest on admission ,670 ,693 ,936 1 ,333 1,954
Tiroﬁban -,602 ,450 1,789 1 ,181 ,548
Drug Eluting Stent -,237 ,429 ,306 1 ,580 ,789
Thrombus Aspiration ,030 ,559 ,003 1 ,957 1,030
Direct Stent -,219 ,401 ,299 1 ,156 ,803
Cardiogenic Shock ,605 ,427 2,012 1 ,216 1,832
Right Coronary Artery ,501 ,405 1,531 1 ,145 1,650
Circumﬂex Artery -,428 ,294 2,126 1 ,039 ,652
SYNTAX Score >22 ,602 ,292 4,255 1 ,039 1,825
GRACE score > 140 ,834 ,297 7,869 1 ,005 2,303
Constant -,662 ,483 1,878 1 ,171 ,516
No-reﬂow phenomenon during primary percutaneous coronary intervention, GRACE score >
140 and SYNTAX score > 22 were the best predictors of atrioventricular conduction block
development.Table 1. General charasteristics of the patients.
AVCB (-) AVCB (+) p value
Age (year) 63.512.3 67.111.4 0.039
Systolic Blood Pressure (mmHg) 131.825.8 101.130.2 <0.001
Diastolic Blood Pressure (mmHg) 80.715.8 61.518.2 <0.001
Troponin Index (Troponin-I/Body
surface area)
32.932.1 43.439.5 0.032
Creatinine (mg/dl) 0.960.64 1.170.62 0.026
GFR(ml/min/1.73 m2) 88.234.7 77.939.0 0.138
Potassium (mEq/L) 4.512.49 4.361.72 0.823
Blood Glucose (mg/dl) 146.965.9 160.494.5 0.050
Ejection Fraction (%) 46.37.2 42.68.9 0.001
Symptom-to-door time (hour) 4.324.0 4.764.57 0.466
Door-to-balloon time (minute) 21.76.1 21.35.9 0.600
Diabetes Mellitus (n¼62) 49 (%17.4) 13 (%22.4) 0.357
Cardiogenic Shock (n¼42) 25 (%8.9) 17 (%29.3) <0.001
Mortality (n¼20) 11 (%3.9) 9 (%15.5) 0.001
Ventricular Arrhythmias (n¼46) 30 (%10.7) 16 (%27.6 0.001
Temporary Pacemaker (n¼23) 12 (%4.3) 11 (%11) <0.001
Permanent Pacemaker (n¼11) 0 11 (%19) 0.001
_Inferior+Right Ventricular STEMI
(n¼172)
134
(%47.7)
38 (%65.5) 0.001
GRACE score in hospital 148.537.8 185.949.7 <0.001
SYNTAX score 20.89.2 22.110.2 0.322
Balloon diameter (mm) 2.110.68 2.120.64 0.892
Stent diameter (mm) 3.020.77 3.140.70 0.345
Stent length (mm) 24.012.4 26.913.8 0.182
Tiroﬁban usage (n¼51) 40 (%14.2) 11 (%19) 0.359
Drug Elauting Stent _Implantation
(n¼46)
42 (%14.9) 4 (%6.9) 0.103
Direct Stenting (n¼53) 45 (%16) 8 (%13.8) 0.672
Thrombus Aspiration (n¼25) 20 (%7.1) 5 (%8.6) 0.690
Coronary blood ﬂow < TIMI III (n¼63) 45 (%16) 18 (%31) 0.007
AVCB; Atrioventricular conduction block, GFR; Glomerular Filtration Rate, STEMI; ST elevation
myocardial infarction.
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Purpose: The Global Registry for Acute Coronary Events (GRACE) and the
Thrombolysis in Myocardial Infarction (TIMI) risk scores predict adverse clinical
outcomes in patients with non-ST elevation acute coronary syndromes (NSTEACS).
In the present study, we sought to determine whether GRACE and TIMI risk scores
correlate with angiographic extent and complexity of coronary artery disease (CAD)
according to SYNTAX score (SXscore) in patients with NSTEACS undergoing
catheterization.
Methods: We performed a retrospective analysis of 167 consecutive NSTEACS
patients (mean age: 5911 years) who underwent coronary angiography and had at
least one signiﬁcant vessel disease (>50% stenosis in a vessel 1.5 mm). SXscore,
a marker of CAD severity, was assessed from angiograms using the SXscore algo-
rithm as described in detail on the SXscore web site. In order to investigate predictive
ability of clinical risk scores in determination of CAD severity, patients were divided
into 3 groups according to their GRACE risk scores: GRACE scores 0 to 108 (low,
n¼68), 109 to 140 (intermediate, n¼51), and >140 (high, n¼48). Similarly, patients
were classiﬁed into 3 categories according to TIMI risk scores: TIMI scores 0 to 2
(low, n¼51), 3 to 4 (intermediate, n¼94), and 5 to 7 (high, n¼21).
Results: The SXscore ranged from 2 to 76 with a mean value of 17.514.0. There
were signiﬁcant correlations between SXscore and GRACE (r¼0.260, p¼0.001) and
TIMI (r¼0.222, p¼0.004) risk scores. There was a signiﬁcant trend for higher
SXscore in higher GRACE and TIMI score groups (Table 1 and 2).
Conclusion: In patients with NSTEACS, both GRACE and TIMI risk scores are
correlated with the extent and severity of CAD. Therefore, in patients with higher
GRACE and TIMI risk scores, CAD can be predicted to be more diffuse and severe.Table 2. SYNTAX score for TIMI risk score categories
Low (0 - 2)
Intermediate
(3 - 4) High (5 - 7) P value
SYNTAX score 13.7  10.9 17.5  13.3 27.2  19.4 0.001
Table 1. SYNTAX score for GRACE risk score categories
Low (0-108)
Intermediate
(109-140) High (>140) P value
SYNTAX score 12.9  10.0 20.1  16.5 21.2  14.5 0.002OP-063
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